WASHINGTON, DC - April 24: James Lovett, corporate senior vice president of Covance Laboratories, testifies during the House Energy and Commerce Subcommittee on Health hearing on overhauling the FDA. Rep. John D. Dingell is putting his considerable clout behind an ambitious import safety and Food and Drug Administration overhaul bill. But the opposition it is generating from almost every corner of the business world may prove to be a formidable counterweight. From local port authorities to...
Copyright Congressional Quarterly Inc.